University of New Mexico invests $100,000 in SolaranRx
STC.UNM Co-Investment Fund has provided $100,000 to SolaranRx. Albuquerque, New Mexico-based SolaranRx is developing therapies and companion imaging agents to treat metastatic melanoma. STC.UNM, which was formerly known as the Science & Technology Corporation @ UNM, is a nonprofit corporation formed and owned entirely by the University of New Mexico Board of Regents.
4 May 2015•3 mins read
